StonvexLoading…
StonvexStonvexStonvexCore line items from RNST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $338.12M | $1.26B | $915.33M | $564.23M |
Operating Income | $110.42M | $226.73M | $129.90M | $54.63M |
Net Income | $88.23M | $181.27M | $102.32M | $1.02M |
EPS (Diluted) | $0.94 | $2.07 | $1.20 | $0.53 |
Total Assets | $27.11B | $26.75B | $26.73B | $26.62B |
Total Liabilities | $23.24B | $22.87B | $22.90B | $22.85B |
Cash & Equivalents | $1.22B | $1.07B | $1.08B | $1.38B |
Free Cash Flow OCF − CapEx | $93.73M | $237.75M | $133.99M | $13.87M |
Shares Outstanding | 92.88M | 94.64M | 95.02M | 95.02M |